Literature DB >> 34205751

Evaluation of SARS-CoV-2 in the Vaginal Secretions of Women with COVID-19: A Prospective Study.

Elad Barber1,2, Michal Kovo1,2, Sophia Leytes1,2, Ron Sagiv1,2, Eran Weiner1,2, Orna Schwartz2,3, Margarita Mashavi2,4, Keren Holtzman2,5, Jacob Bar1,2, Anat Engel2,5, Shimon Ginath1,2.   

Abstract

OBJECTIVE: We aimed to investigate the likelihood of vaginal colonization with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant and non-pregnant women with Coronavrus Disease 2019 (COVID-19).
MATERIALS AND METHODS: Vaginal swabs were taken from women diagnosed with mild to moderately acute SARS-CoV-2 infection, at Wolfson Medical Center, Israel, from March 2020 through October 2020. COVID-19 was diagnosed by real-time polymerase chain reaction (RT-PCR) performed on nasopharyngeal swabs. Vaginal swabs were tested for the presence of SARS-CoV-2 by reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: In total, 51 women diagnosed with COVID-19 were included in the study. Of the 51 women with COVID-19 enrolled in this study, 16 (31.4%) were pregnant at enrollment and 35 (68.6%) were non-pregnant. Mean age was 43.5 ± 15.3 years (range 21-74 years). Compared to the non-pregnant group, the pregnant group was characterized by a higher white blood cell and absolute neutrophil count (p = 0.02 and p = 0.027, respectively). The non-pregnant patients were more likely to have chronic diseases (p = 0.035) and to be hospitalized (p < 0.001). Only one patient (1.9%) aged 60 years tested positive for SARS-CoV-2 in vaginal secretions. Mean gestational age at the diagnosis of COVID-19 of the pregnant group was 32.3 ± 7.8 weeks. Thirteen patients delivered during the study period; all delivered at term without obstetric complications and all neonates were healthy.
CONCLUSIONS: Detection of SARS-CoV-2 in the vaginal secretions of patients diagnosed with COVID-19 is rare. Vaginal colonization may occur during the viremia phase of the disease, although infectivity from vaginal colonization needs to be proven.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; vaginal secretions

Year:  2021        PMID: 34205751     DOI: 10.3390/jcm10122735

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

1.  Detection of SARS-CoV-2 contamination in the operating room and birthing room setting: a cross-sectional study.

Authors:  Patricia E Lee; Robert Kozak; Nasrin Alavi; Hamza Mbareche; Rose C Kung; Kellie E Murphy; Darian Perruzza; Stephanie Jarvi; Elsa Salvant; Noor Niyar N Ladhani; Albert J M Yee; Louise-Helene Gagnon; Richard Jenkinson; Grace Y Liu
Journal:  CMAJ Open       Date:  2022-05-24

2.  Effects of COVID-19 and mRNA vaccines on human fertility.

Authors:  Fei Chen; Shiheng Zhu; Zhiqing Dai; Lanting Hao; Chun Luan; Qi Guo; Chaofan Meng; Yankun Zhang
Journal:  Hum Reprod       Date:  2021-12-27       Impact factor: 6.353

Review 3.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

Review 4.  RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease.

Authors:  Chandrasekharan Rajalekshmi Dhanya; Aswathy Shailaja; Aarcha Shanmugha Mary; Sumodan Padikkala Kandiyil; Ambili Savithri; Vishnu Sasidharan Lathakumari; Jayakrishnan Therthala Veettil; Jiji Joseph Vandanamthadathil; Maya Madhavan
Journal:  Pathogens       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.